Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 3 matching records.
3 results — page 1 of 1
- Level BClinical TrialPubMed
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation.
Clinical Trial on Immune Modulation, published in Curr Opin Organ Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Curr Opin Organ Transplant - Level DNarrative ReviewPubMed
Immunomodulation in Vascularized Composite Allotransplantation: What Is the Role for Adipose-Derived Stem Cells?
Narrative Review on Immune Modulation, published in Ann Plast Surg (2019) — summary generated from the PubMed abstract.
- 2019
Ann Plast Surg17 citations - Level DAnimal StudyPubMed
The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Animal Study on Immune Modulation, published in Transplantation (2017) — summary generated from the PubMed abstract.
- 2017
Transplantation
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406